Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

1
Player Avatar Jaaaaason (< 20) Submitted: 1/18/2012 6:35:12 PM : Outperform Start Price: $1.65 ARNA Score: +262.96

safest obesity drug in trial

Featured Broker Partners


Advertisement